title: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab.
authors.forename: T
authors.initials: T
authors.lastname: Davis
authors.forename: R E
authors.initials: RE
authors.lastname: Gore-Langton
authors.forename: B D
authors.initials: BD
authors.lastname: Cheson
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D016393:Lymphoma, B-Cell / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab